AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...
The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...
In preclinical animal trials, third-party testing results showed that AIM Vaccine's mRNA RSV vaccine achieved significantly higher levels of specific IgG antibody titers, live-virus neutralizing ...
HONG KONG SAR - Media OutReach Newswire – 5 February 2025 - AIM Vaccine Co., Ltd. (06660), a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory ...
Zacks Investment Research on MSN3d
ADMA Loses 8.9% in a Month: How Should You Play the Stock?ADMA Biologics’ ADMA shares have lost 8.9% in a month against the industry’s growth of 6.6%. The company has put up a ...
COVID-19 is a distinctive infection characterized by elevated inter-human transmission and presenting from absence of symptoms to severe cytokine storm that can lead to dismal prognosis. Like for HIV, ...
Scientists at the Institute for Systems Biology (ISB) have uncovered key insights into how T cells—the body's frontline ...
In a breakthrough for influenza research, scientists have discovered immune cells that can recognize influenza (flu) viruses ...
Discover how psychoneuroimmunology transforms trauma therapy by addressing the immune system's role in health, regulation, ...
Scientists have uncovered a mechanism for reinvigorating the immune system to stop it from flagging when it’s fighting ...
4d
While researchers don’t currently know why women are at greater risk of long COVID, differences in the way men’s and women’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback